Ipswich Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,000
Closed -$250K 177
2022
Q2
$250K Sell
5,000
-2,400
-32% -$127K 0.07% 162
2022
Q1
$380K Hold
7,400
0.09% 143
2021
Q4
$371K Sell
7,400
-11,455
-61% -$567K 0.09% 155
2021
Q3
$909K Sell
18,855
-400
-2% -$20.3K 0.23% 101
2021
Q2
$1.01M Buy
19,255
+400
+2% +$20.9K 0.26% 96
2021
Q1
$933K Sell
18,855
-2,800
-13% -$135K 0.26% 92
2020
Q4
$1.05M Buy
21,655
+6,000
+38% +$296K 0.32% 82
2020
Q3
$785K Buy
+15,655
New +$806K 0.25% 87

Other funds holding SNY

Ipswich Investment Management's SNY Position: Q3 2022 in Review

Ipswich Investment Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 5,000 shares — an estimated $250K sold.

Ipswich Investment Management first reported a position in SNY in Q3 2020 and held it in 8 quarters. The position peaked at $1.05M in Q4 2020. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Ipswich Investment Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Ipswich Investment Management sold 5,000 Sanofi shares in Q3 2022, an estimated $250K.
  • Ipswich Investment Management first reported a position in Sanofi in Q3 2020 and held it in 8 quarters.
  • Ipswich Investment Management's Sanofi position peaked at $1.05M in Q4 2020.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Ipswich Investment Management's 13F filing for Q3 2022, filed 11 Oct 2022.